PERFECTRA: A pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs

Celine J. van de Laar*, Martijn A.H. Oude Voshaar, Peter ten Klooster, Danyta I. Tedjo, Reinhard Bos, Tim Jansen, A. Willemze, Grada A. Versteeg, Y.P.M. Goekoop-Ruiterman, Eric-Jan Kroot, Mart van de Laar

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
22 Downloads (Pure)

Fingerprint

Dive into the research topics of 'PERFECTRA: A pragmatic, multicentre, real-life study comparing treat-to-target strategies with baricitinib versus TNF inhibitors in patients with active rheumatoid arthritis after failure on csDMARDs'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science